rs2278741

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001374353.1(GLI2):​c.*816G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.606 in 152,546 control chromosomes in the GnomAD database, including 29,689 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.61 ( 29568 hom., cov: 32)
Exomes 𝑓: 0.70 ( 121 hom. )

Consequence

GLI2
NM_001374353.1 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.257

Publications

13 publications found
Variant links:
Genes affected
GLI2 (HGNC:4318): (GLI family zinc finger 2) This gene encodes a protein which belongs to the C2H2-type zinc finger protein subclass of the Gli family. Members of this subclass are characterized as transcription factors which bind DNA through zinc finger motifs. These motifs contain conserved H-C links. Gli family zinc finger proteins are mediators of Sonic hedgehog (Shh) signaling and they are implicated as potent oncogenes in the embryonal carcinoma cell. The protein encoded by this gene localizes to the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. The encoded protein is associated with several phenotypes- Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI2 Gene-Disease associations (from GenCC):
  • holoprosencephaly 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, Ambry Genetics
  • combined pituitary hormone deficiencies, genetic form
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • holoprosencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 2-120991491-G-C is Benign according to our data. Variant chr2-120991491-G-C is described in ClinVar as Benign. ClinVar VariationId is 331006.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.725 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLI2NM_001374353.1 linkc.*816G>C 3_prime_UTR_variant Exon 14 of 14 ENST00000361492.9 NP_001361282.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLI2ENST00000361492.9 linkc.*816G>C 3_prime_UTR_variant Exon 14 of 14 1 NM_001374353.1 ENSP00000354586.5 A0A7I2PJA1

Frequencies

GnomAD3 genomes
AF:
0.607
AC:
92169
AN:
151956
Hom.:
29559
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.397
Gnomad AMI
AF:
0.803
Gnomad AMR
AF:
0.627
Gnomad ASJ
AF:
0.673
Gnomad EAS
AF:
0.476
Gnomad SAS
AF:
0.510
Gnomad FIN
AF:
0.661
Gnomad MID
AF:
0.690
Gnomad NFE
AF:
0.730
Gnomad OTH
AF:
0.634
GnomAD4 exome
AF:
0.697
AC:
329
AN:
472
Hom.:
121
Cov.:
0
AF XY:
0.702
AC XY:
205
AN XY:
292
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
2
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.701
AC:
300
AN:
428
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.658
AC:
25
AN:
38
Other (OTH)
AF:
0.500
AC:
2
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.606
AC:
92185
AN:
152074
Hom.:
29568
Cov.:
32
AF XY:
0.602
AC XY:
44748
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.397
AC:
16446
AN:
41476
American (AMR)
AF:
0.627
AC:
9579
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.673
AC:
2335
AN:
3470
East Asian (EAS)
AF:
0.476
AC:
2455
AN:
5162
South Asian (SAS)
AF:
0.510
AC:
2450
AN:
4802
European-Finnish (FIN)
AF:
0.661
AC:
6991
AN:
10580
Middle Eastern (MID)
AF:
0.701
AC:
206
AN:
294
European-Non Finnish (NFE)
AF:
0.730
AC:
49653
AN:
67988
Other (OTH)
AF:
0.636
AC:
1341
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1708
3416
5124
6832
8540
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
754
1508
2262
3016
3770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.551
Hom.:
1731
Bravo
AF:
0.592
Asia WGS
AF:
0.492
AC:
1709
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Holoprosencephaly 9 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
7.2
DANN
Benign
0.70
PhyloP100
-0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2278741; hg19: chr2-121749067; COSMIC: COSV58040492; COSMIC: COSV58040492; API